EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of an Elusive CBFA2T3::GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing

Yuna Lee, Jung Yoon Choi, Hyun Jin Park, Bo Kyung Kim, Hyun Kyung Kim iD, Yeseul Kim, Jung-Eun Cheon, Sung-Hye Park, Ji Hoon Phi, Ji Won Lee, Ryul Kim, June-Young Koh iD und 1 weitere

eJHaem · 2026-04 · 7 (2)

DOI: 10.1002/jha2.70254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 25.03.2026. Verfasst von Yuna Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Inocras Inc. San Diego California USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advancements in genomic profiling have significantly improved the classification and treatment strategies for acute myeloid leukemia (AML). However, widely utilized molecular diagnostic techniques, including targeted gene panels, are often insufficient for detecting complex structural variants, cryptic fusions, and poorly characterized driver mutations. Here, we present the case of a 15‐month‐old female with pediatric acute megakaryoblastic leukemia (AMKL) who exhibited an atypical clinical presentation. Initial imaging revealed expansile lesions in the pelvic bones and vertebral bodies, prompting suspicion of malignancy. Conventional diagnostics, including immunohistochemistry and targeted sequencing, failed to identify a definitive oncogenic driver. Whole genome sequencing (WGS) identified a CBFA2T3::GLIS2 fusion, leading to a revised AMKL diagnosis with a RAM immunophenotype. The patient underwent induction chemotherapy with cytarabine and mitoxantrone, followed by salvage therapy with venetoclax and azacitidine, resulting in morphologic remission. Subsequent haploidentical hematopoietic stem cell transplantation achieved remission, with ongoing hematologic recovery. This case underscores the limitations of conventional molecular assays in detecting cryptic fusions and highlights the critical role of comprehensive genomic profiling in refining subclassification and optimizing therapeutic strategies in pediatric AML.

Autor:innen und Institutionen

  • Inocras Inc. San Diego California USA.
  • Department of Pediatrics Seoul National University College of Medicine Seoul National University Children's Hospital Seoul Republic of Korea.
  • Seoul National University Cancer Research Institute Seoul Republic of Korea.
  • Department of Laboratory Medicine Seoul National University Hospital Seoul National University College of Medicine Seoul Republic of Korea.
  • Department of Radiology Seoul National University Children's Hospital Seoul National University College of Medicine Seoul Republic of Korea.
  • Department of Pathology Seoul National University Hospital Seoul National University College of Medicine Seoul Republic of Korea.

ORCID-Profile: Hyun Kyung Kim, June-Young Koh

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Lee, Y., Choi, J. Y., Park, H. J., Kim, B. K., Kim, H. K., Kim, Y., Cheon, J. E., Park, S. H., Phi, J. H., Lee, J. W., Kim, R., Koh, J. Y., & Kang, H. J. (2026). Identification of an Elusive CBFA2T3::GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing. eJHaem, 7(2). https://doi.org/10.1002/jha2.70254

Vancouver

Lee Y, Choi JY, Park HJ, Kim BK, Kim HK, Kim Y, et al. Identification of an Elusive CBFA2T3::GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing. eJHaem. 2026;7(2). doi:10.1002/jha2.70254

BibTeX
@article{Lee2026,
  author = {Lee, Yuna and Choi, Jung Yoon and Park, Hyun Jin and Kim, Bo Kyung and Kim, Hyun Kyung and Kim, Yeseul and Cheon, Jung-Eun and Park, Sung-Hye and Phi, Ji Hoon and Lee, Ji Won and Kim, Ryul and Koh, June-Young and Kang, Hyoung Jin},
  title = {Identification of an Elusive CBFA2T3::GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.1002/jha2.70254}
}
Kostenlos starten →